Company Info
| Year Established: | 2019 |
Contacts
| Primary: | Greg Vontz CEO |
| Other: | Tomas Babak, PhD Founder and CSO Peter Heinecke CBO & General Counsel |
Company Description
Leapfrog Bio is a clinical-stage precision oncology company accelerating cancer drug development by identifying clinical stage molecules that can be retargeted as directed therapies for cancers with undruggable driver mutations.
